Latest Think.Health News
Mar 16, 2021
NEW YORK ─ Molecular diagnostics firm Inflammatix on Tuesday announced the closing of a $102 million Series D financing to support the development and commercialization of its immune-response diagnostic tests. D1 Capital Partners led the round and current investors, including Northpond Ventures, Khosla Ventures, Think.Health, and OSF Healthcare Ventures, also participated. To read the full story.... Email:
1 Team Member
Think.Health has 1 team member, including current Managing Partner, Florian Kainzinger.